Ezetimibe inhibits the migration and invasion of triple‐negative breast cancer cells by targeting TGFβ2 and EMT
Article in FEBS Open Bio (March 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in FEBS Open Bio (March 2024)
Article in Cells (January 2024)
Article in Heliyon (October 2023)